

Synapse is an oral cognitive optimization protocol built around Dihexa, a synthetic peptide derived from angiotensin IV that crosses the blood-brain barrier to promote the formation of new synaptic connections. Unlike neurotransmitter-based nootropics that provide temporary stimulation, Dihexa drives structural changes in neural architecture through synaptogenesis, supporting lasting improvements in memory, learning capacity, focus, and cognitive resilience. Taken as a daily oral capsule with no injections required. Suited for patients experiencing brain fog, age-related cognitive decline, or those seeking serious cognitive performance optimization.
Synapse targets the structural foundation of cognitive function: the density and quality of synaptic connections between neurons. It is designed for patients experiencing brain fog, memory decline, difficulty with focus or information processing, age-related cognitive slowing, or those who want to build long-term cognitive resilience. This is not a stimulant. It drives the formation of new neural architecture.
Dihexa crosses the blood-brain barrier and activates the hepatocyte growth factor (HGF) / c-Met receptor pathway, which governs neuron survival and synapse formation. This triggers synaptogenesis, the creation of new functional connections between neurons. The result is increased synaptic density and improved neural communication. Taken as a daily oral capsule. Effects build cumulatively over 4 to 12 weeks.
Dihexa is a powerful compound with emerging research. We take that seriously. Every Synapse protocol starts with a clinical consultation to evaluate your cognitive history, goals, and risk factors. We source pharmaceutical-grade Dihexa from licensed compounding pharmacies and monitor your response throughout the protocol. Lincoln Park clinic or statewide telehealth. No shortcuts on clinical oversight.


We're here to answer your questions and provide the best services for your needs. Schedule a consultation to learn how to reach your aesthetic goals.
Your Synapse protocol begins with a clinical consultation at our Lincoln Park clinic at 2117 N Halsted St or via telehealth for patients anywhere in Illinois. Your provider reviews your cognitive history, current medications (including any existing nootropic use), medical history, and the specific concerns driving your interest in cognitive peptide therapy. Dihexa activates a potent growth pathway (HGF/c-Met), which means clinical screening matters more than it does for milder nootropics. Your provider will assess whether Dihexa is appropriate for your situation and recommend the right starting dose.
Synapse (5mg capsule, 30-count): The standard starting point for most patients. One capsule daily, taken in the morning. The 5mg dose aligns with the formulations used across clinical peptide practices and provides a conservative entry point for assessing individual tolerance. Most patients begin here and stay here, as the 5mg dose is sufficient for meaningful cognitive benefits in the majority of cases. This is the recommended starting formulation for all new patients.
Synapse Pro (25mg capsule, 30-count): A higher-dose formulation for patients who have demonstrated good tolerance on the 5mg protocol for at least 4 to 6 weeks and want to pursue a more aggressive cognitive enhancement timeline, or for patients whose provider determines a higher starting dose is clinically appropriate based on their specific presentation. One capsule daily, taken in the morning. Given Dihexa's long half-life (approximately 12 days), some providers use intermittent dosing schedules at the 25mg level, such as 5 days on / 2 days off, to manage steady-state accumulation. Your provider will specify the right schedule.
Dihexa's effects are not like a stimulant. There is no immediate rush of focus or energy. What patients typically describe is a gradual sharpening over the first 2 to 4 weeks: less brain fog, easier recall, faster processing of new information, and a sense that complex tasks feel more manageable. More substantial improvements in memory and learning capacity typically develop over 6 to 12 weeks as synaptic density increases and neural networks strengthen. Because Dihexa promotes structural changes in synaptic architecture rather than temporary neurotransmitter modulation, improvements often persist beyond the treatment period.
Potential side effects are generally mild. Some patients report headache, changes in sleep patterns, mild nausea, or mood fluctuation during the first week. These typically resolve as the body adjusts. Your provider monitors your response throughout the protocol and will adjust dosing or schedule if needed.
We want to be transparent about where the research stands. Dihexa has demonstrated remarkable results in preclinical (animal) studies, including significant improvements in synaptic density, neuronal survival, and spatial memory in rodent models of cognitive impairment. It was originally developed at Washington State University and has been patented for potential use in Alzheimer's disease and other neurodegenerative conditions. However, there are no completed large-scale human clinical trials. The clinical use of Dihexa in wellness and longevity settings is based on the preclinical evidence combined with growing clinical observation from providers who prescribe it off-label. Your provider at Better Med Spa will discuss what the evidence does and does not support during your consultation so you can make an informed decision.
Synapse pairs naturally with several protocols on the Better Med Spa menu. The most common combination is Synapse + NeuroFocus & Flow (Semax + Selank) for patients who want both structural neural improvement (synaptogenesis via Dihexa) and real-time cognitive performance enhancement (neurotransmitter modulation via Semax/Selank). For patients building a comprehensive brain health stack, adding Better Vitality NAD+ provides mitochondrial and DNA repair support that complements the neural architecture work Dihexa is doing. Patients focused on combined cognitive and cellular longevity often include Core Spark (SS-31) and Cellular Longevity (Epithalon).
Find out if Synapse (Dihexa) is right for your cognitive goals.
Book a consultation at Better Med Spa in Lincoln Park or via telehealth. We'll evaluate your history, screen for contraindications, and recommend the right dose.
Oral cognitive peptide therapy that builds new neural connections. No injections. 5mg from $295/mo, 25mg at $625/mo at Better Med Spa.
Most nootropics work by modulating neurotransmitters. They increase dopamine, acetylcholine, serotonin, or GABA to produce short-term improvements in focus, mood, or alertness. When you stop taking them, the effects fade because nothing structural has changed in your brain. Dihexa operates on a fundamentally different level. It drives synaptogenesis: the creation of new functional synaptic connections between neurons. Instead of turning up the volume on existing circuits, Dihexa helps your brain build new ones.
Dihexa (chemical name N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, development code PNB-0408) is a synthetic peptide derived from angiotensin IV, originally developed by researchers at Washington State University as a potential therapy for Alzheimer's disease. It crosses the blood-brain barrier and activates the hepatocyte growth factor (HGF) / c-Met receptor pathway, a signaling system that governs neuron survival, synaptic formation, and neural circuit repair. In preclinical models, Dihexa has shown the ability to increase synaptic markers like synaptophysin, improve neuronal counts in the hippocampus, and restore spatial memory and learning capacity in cognitively impaired animals. Researchers have noted that its potency in synaptic assays is orders of magnitude greater than brain-derived neurotrophic factor (BDNF), the body's primary natural driver of neuroplasticity.
At Better Med Spa in Lincoln Park, Chicago, we offer Dihexa under the protocol name Synapse as a clinician-guided oral capsule protocol. It is available in two strengths (5mg and 25mg) with dosing tailored to your cognitive goals, tolerance, and clinical history.
The HGF/c-Met pathway is one of the brain's core growth and repair systems. Hepatocyte growth factor (HGF) binds to the c-Met receptor on neurons, triggering downstream signaling cascades that promote cell survival, axon growth, and the formation of new synapses. This pathway is active during brain development and plays a role in neural repair after injury. In healthy adults, its activity declines with age, contributing to the progressive loss of synaptic density and cognitive flexibility that most people experience starting in their 40s and 50s.
Dihexa mimics HGF and activates the c-Met receptor directly. When it crosses the blood-brain barrier and binds to c-Met, it initiates synaptogenesis: new dendritic spines form, synaptic connections strengthen, and neurons that were alive but under-connected begin to integrate more fully into functional networks. The practical result is improved communication between brain regions, which translates into better memory encoding, faster recall, sharper focus, and enhanced ability to learn and process new information.
This is fundamentally different from what Semax, Selank, racetams, or traditional stimulants do. Those compounds modulate neurotransmitter levels for immediate performance effects. Dihexa builds the hardware. The two approaches are complementary, which is why patients at Better Med Spa often pair Synapse with NeuroFocus & Flow (Semax + Selank) for both structural improvement and real-time cognitive output.
One pharmacokinetic detail worth noting: Dihexa has an unusually long half-life of approximately 12 days. This means the compound accumulates to steady-state concentrations over several weeks of daily dosing. Effects are cumulative, not immediate. Patients should expect to invest 4 to 12 weeks before the full cognitive benefits become apparent. This also means that some of the improvements persist after discontinuation, because the new synaptic connections Dihexa helped create remain in place.
At Better Med Spa in Lincoln Park, we see Synapse fitting into several patient profiles:
Brain fog and cognitive fatigue. Patients who describe a persistent mental haze, difficulty concentrating, or a sense that their cognitive sharpness has declined. These complaints are common among busy professionals in Lincoln Park, River North, and the Loop who manage high cognitive loads daily and notice that their mental endurance is not what it used to be. Synapse addresses the structural substrate of these complaints rather than masking them with stimulants.
Age-related cognitive decline. Patients over 40 who notice measurable changes in memory, processing speed, or the ability to learn new information. Synaptic density declines naturally with age, and Dihexa's mechanism directly targets that loss. For patients who want to slow or partially reverse age-related cognitive changes, Synapse offers an approach that no traditional nootropic can replicate.
High-performance cognitive demands. Executives, founders, attorneys, traders, and other professionals in demanding roles who view cognitive optimization as a competitive advantage. These patients are often already using Semax or Selank for daily focus and want to add a structural layer underneath. Synapse is the long-game investment; NeuroFocus & Flow is the daily performance tool.
Post-concussion and traumatic brain injury support. Patients recovering from head injuries who are looking for adjunctive support for cognitive rehabilitation. Dihexa's ability to promote neural circuit repair and neuron survival has generated interest in the TBI recovery space. This remains an emerging application and should be discussed carefully with your provider, but for patients who have plateaued with conventional rehabilitation, Synapse may offer an additional pathway.
Longevity and neuroprotection stack builders. Patients assembling a comprehensive cognitive longevity protocol alongside Better Vitality NAD+, Core Spark (SS-31), and Cellular Longevity (Epithalon). Synapse adds the synaptogenesis layer that no other compound on the menu provides.
Dihexa activates the HGF/c-Met pathway, which is a known growth signaling cascade. This means it carries theoretical concerns around stimulating growth in tissues where growth is not desired. Patients with a personal or strong family history of cancer should discuss this carefully with their provider before starting. Dihexa is not recommended for patients who are pregnant or breastfeeding. Patients with active neurological conditions beyond the scope of cognitive optimization should consult their neurologist before adding Dihexa to their protocol. At Better Med Spa, we screen for all of these factors during the consultation and will not prescribe without a clinical evaluation.
Formulation: 5mg oral capsule, 30-count
Dosing: 1 capsule daily, taken in the morning
Supply: 30-day supply
Best for: All new patients, daily cognitive support, brain fog, memory improvement, focus optimization
3-month commitment: $265/month ($795 total)
Formulation: 25mg oral capsule, 30-count
Dosing: 1 capsule daily or intermittent schedule as prescribed
Supply: 30-day supply
Best for: Patients with demonstrated tolerance on 5mg seeking accelerated cognitive enhancement, provider-directed higher-dose protocols
3-month commitment: $575/month ($1,725 total)
Both formulations include your clinical consultation, pharmaceutical-grade compounded Dihexa from a licensed pharmacy, and ongoing provider access for dosing adjustments and monitoring. No injections required. No separate consultation fees. Pricing is transparent and all-inclusive.
Most patients start on the 5mg capsule and stay there. The 25mg formulation is available for patients who have completed at least one month on the standard dose with good tolerance and whose provider determines a higher dose is appropriate. We do not prescribe the 25mg formulation as a starting dose without clinical justification.
The flagship cognitive stack. Dihexa builds new synaptic connections (structural improvement) while Semax and Selank modulate neurotransmitter signaling for real-time focus, clarity, and anxiety reduction (performance output). Together, you're building better hardware and running better software simultaneously. This is the most common cognitive pairing at Better Med Spa for professionals in Lincoln Park, Gold Coast, and River North.
NAD+ supports mitochondrial function and DNA repair across all cell types, including neurons. Pairing NAD+ with Dihexa ensures that the neurons forming new synaptic connections have the cellular energy infrastructure to sustain them. A strong combination for patients over 50 or those with concurrent fatigue and cognitive concerns.
SS-31 stabilizes the inner mitochondrial membrane, protecting neurons from oxidative damage and energy depletion. Combined with Dihexa's synaptogenesis, this creates a dual-layer approach: build new connections and protect the cells that house them. Positioned for the deep longevity patient.
For patients with both cognitive and nerve-related concerns. ARA-290 targets peripheral nerve repair and inflammation through the innate repair receptor, while Dihexa works centrally on synaptic architecture. Different mechanisms, complementary targets.
Yes. Dihexa pairs particularly well with Semax and Selank (neurotransmitter modulation for real-time cognitive performance), NAD+ (mitochondrial support for neuronal energy), and SS-31 (mitochondrial membrane protection). Some patients also combine Dihexa with choline donors like Alpha-GPC or citicoline to support the raw materials needed for synapse function. All combinations are reviewed by your provider.
Most patients report initial improvements in clarity and focus within 2 to 4 weeks. More substantial cognitive benefits, including memory enhancement and improved learning capacity, typically develop over 6 to 12 weeks as synaptic density increases. Dihexa has a long half-life (approximately 12 days), so effects are cumulative and build over time. This is not a stimulant; do not expect immediate results on day one.
No. Dihexa has not been tested in large-scale human clinical trials and does not hold FDA approval for any indication. The existing evidence base comes from preclinical (animal) studies conducted primarily at Washington State University, where the compound was developed and patented for potential use in Alzheimer's disease. At Better Med Spa, Dihexa is prescribed off-label under clinician supervision through a licensed compounding pharmacy. We are transparent about the current state of the evidence and discuss it with every patient during consultation.